Altogether, overwhelming evidence points to an important role for all three PPARs in insulin signaling and glucose level management, and to several compounds with similar potential, including some that block the endogenous ligand-induced activation of PPARγ for the treatment of the metabolic syndrome and T2D [436,443,444]. This evidence concerns the gene INS and metabolic syndrome.